Johnson & Johnson Announces $55 Billion Investment in U.S. Manufacturing and Innovation
J&J will invest over $55 billion in the U.S. over the next 4 years (2025-2029)
This represents a 25% increase compared to the previous 4 years
The investment includes building 3 new advanced manufacturing facilities
J&J is breaking ground on a $2 billion biologics plant in Wilson, North Carolina
The plan also includes expanding existing manufacturing sites
Investments will be made in R&D infrastructure and technology
Key Details:
The North Carolina plant will be 500,000 square feet and create about 500 new jobs
It will produce medicines for cancer, immunology and neuroscience
Total economic impact estimated at over $100 billion per year
Investment builds on J&J's 140-year history of U.S. innovation
Aims to strengthen U.S. manufacturing capabilities and create jobs
Follows similar recent announcements by other pharma companies like Eli Lilly